000 | 00979 a2200313 4500 | ||
---|---|---|---|
005 | 20250512011638.0 | ||
264 | 0 | _c19900504 | |
008 | 199005s 0 0 jpn d | ||
022 | _a0009-918X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYoshida, M | |
245 | 0 | 0 |
_a[Tetrahydroisoquinoline and parkinsonism]. _h[electronic resource] |
260 |
_bRinsho shinkeigaku = Clinical neurology _cDec 1989 |
||
300 |
_a1501-3 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aChemical Phenomena |
650 | 0 | 4 | _aChemistry |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aIsoquinolines _xadverse effects |
650 | 0 | 4 |
_aLevodopa _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
650 | 0 | 4 | _aSaimiri |
650 | 0 | 4 | _aTetrahydroisoquinolines |
773 | 0 |
_tRinsho shinkeigaku = Clinical neurology _gvol. 29 _gno. 12 _gp. 1501-3 |
|
999 |
_c2636041 _d2636041 |